Phase I clinical trial of parenteral hydroxyurea in combination with pelvic and para-aortic external radiation and brachytherapy for patients with advanced squamous cell cancer of the uterine cervix Article

Beitler, JJ, Anderson, P, Haynes, H et al. (2002). Phase I clinical trial of parenteral hydroxyurea in combination with pelvic and para-aortic external radiation and brachytherapy for patients with advanced squamous cell cancer of the uterine cervix . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 52(3), 637-642. 10.1016/S0360-3016(01)02662-1

cited authors

  • Beitler, JJ; Anderson, P; Haynes, H; Sood, B; Fields, A; Goldberg, G; Vikram, B; Runowicz, CD; Wadler, S

sustainable development goals

publication date

  • March 1, 2002

keywords

  • BULKY STAGE-IB
  • CARCINOMA
  • CHEMOTHERAPY
  • CISPLATIN
  • GYNECOLOGIC-ONCOLOGY-GROUP
  • IIB
  • INFUSION
  • IRRADIATION
  • Life Sciences & Biomedicine
  • Oncology
  • PARAAORTIC LYMPH-NODES
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology
  • THERAPY
  • advanced cervical cancer
  • cell synchronization
  • concomitant chemotherapy and radiotherapy
  • hydroxyurea
  • intravenous hydroxyurea
  • radiation sensitizer

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 637

end page

  • 642

volume

  • 52

issue

  • 3